Akon Health Secures Nearly RMB 200 Million in Series B Funding and Launches Regional Integrated Healthcare Platform

On March 16, AKangHealth successfully held its Series B financing round and the strategic launch event for its Regional Medical and Big Health Platform at the group’s headquarters. At the event, AKangHealth announced the completion of a nearly RMB 200 million Series B financing round, led by CICC Qide under CICC Capital, with participation from Zhongke Kechuang, Nanjing Bofu Venture Capital Partnership (Limited Partnership), and Suizi Finance. This marks another milestone in AKangHealth’s valuation in the capital market, following its tens-of-millions RMB Series A financing round led by GF Xinde in 2018.

A New Journey, A New Beginning! The conference witnessed the strategic launch of the AKang Regional Medical and Health Platform, bank-enterprise collaboration to empower grassroots medical financial services, the official opening of the AKang Internet Medical and Health Industrial Park, and the grand opening ceremony of Weikang Pharmacy, one of the first enterprises to settle in the new business format park.

Panorama

The conference specially invited Mr. Dai Hang, Executive Dean of the Research Institute of the China Association of Pharmaceutical Materials, to serve as the moderator. Representatives from capital firms, investment institutions, banking institutions, and AKangHealth’s key strategic partners attended the meeting.

Mr. Dai Hang, Executive Dean of the Research Institute of the China Medical Pharmaceutical Material Association

Mr. Wang Lijue, Chairman of AKangHealth Group, delivered the welcome address at the conference. He expressed his sincere gratitude and appreciation to the government officials, investors, banking institutions, and upstream and downstream partners who have consistently supported AKangHealth’s development and growth. He noted that holding the conference at the group’s headquarters made it akin to a “family reunion,” inviting friends and partners from all sectors to “come home” and jointly witness AKangHealth embarking on its renewed journey toward new horizons. The successful completion of the Series B financing has provided AKangHealth with the momentum to innovate and thrive.

Mr. Wang Lijue, Chairman of AKangHealth Group

Over the next three years, annual sales volume will maintain a 50% growth momentum. By comprehensively optimizing the three core pillars—warehousing system, supply chain system, and R&D system—we will holistically enhance our service capabilities for the grassroots medical medication market. We will strengthen technological innovation and development capabilities, continuously building the AKang Health shared empowerment platform through SaaS systems. In terms of national warehousing and logistics infrastructure, we will establish six major regional central warehouses (totaling 100,000 square meters) and 30 provincial-level shared cloud warehouses across China, continuously reducing the service radius and shortening the delivery time for grassroots patients’ medications from 48 hours to 24 hours, and ultimately to 12 hours. We will accelerate the construction of a national chronic disease customer service center, continuously improving pharmaceutical care services for chronic disease patients at the grassroots level. By exporting standardized service systems to grassroots enterprises, we will empower the industry to upgrade its operational service capabilities.

Accelerate the transformation and upgrading from "pharmaceuticals" to "medical care," from "medical care" to "patients," and from "patients" to "insurance." Based on the "One Body, Five Dimensions" digital operation system, continuously enhance new medical value and expand service connotations. Achieve the developmental progression from "Industry + CSO" to "PBM + CSO." Establish a regional healthcare ecosystem grounded in primary care, empowering and driving the upgrading and transformation of regional commerce, integrating and developing regional new retail and new medical services, with a core focus on serving grassroots populations, thereby building a billion-level primary healthcare platform. Collaborate with pharmaceutical commercial enterprises in various districts to construct over 100 regional healthcare service platforms. Comprehensively promote the enhancement of primary medical service capabilities in China by building localized, integrated healthcare service platforms. Through a regional closed-loop service model integrating "medical care, pharmaceuticals, diagnostics, and insurance," establish a ground-level network for one-stop medical services for grassroots residents, continuously improving the level of primary medical services and resident health management, enabling rural populations to enjoy healthy and fulfilling lives.

Ms. Liang Ying, Head of the CICC Qide Pharmaceutical Fund

Ms. Liang Ying, Head of the CICC Qide Healthcare Fund, expressed strong confidence in AKangHealth’s development potential. With a population of 1.4 billion in China, including 700 million people residing in grassroots communities, 90% of rural areas suffer from shortages of medical resources and pharmaceuticals. Grassroots medical service capacity remains weak and fails to meet the healthcare needs of local residents. Where there are people, there is demand; where there is demand, there is a market. The No. 1 Central Document of 2021 proposed comprehensively advancing rural healthcare revitalization. From both the perspective of market demand and policy support, CICC Qide places significant value on the blue-ocean market of grassroots healthcare and the substantial health needs of grassroots populations. By building a regional integrated healthcare platform driven by its “One Body, Five Dimensions” technology-enabled digital operational system, AKangHealth is undertaking a health initiative of epoch-making significance that benefits grassroots communities. CICC Qide is highly willing to partner with AKangHealth to embark on a new journey in regional comprehensive healthcare. Empowered by capital and driven by the dual engines of financial investment and digital-intelligence integration, we jointly commit to realizing the mission of “making medicines accessible to all.”

Liang Ying, Head of CICC Qide Pharmaceutical Fund; Xie Yong, CEO of Guangdong Zhongke Sci-Tech Venture Capital Management Co., Ltd.; Tan Qingzhong, General Manager of Suizi Finance; Ao Xiaomin, Executive Deputy General Manager of GF Xinde Investment Management Co., Ltd.; Bi Wanfen, Investment Director of Nanjing Bofu Investment Co., Ltd.; and Wang Lijue, Chairman of AKangHealth Group, jointly announced the Series B financing of AKangHealth.

Series B Funding Round Announcement

Mr. Chen Heng, Secretary of the Party Working Committee of Yongping Subdistrict, Baiyun District, Guangzhou City

Mr. Chen Heng, Secretary of the Party Working Committee of Yongping Subdistrict, Baiyun District, Guangzhou City, delivered a congratulatory address. He affirmed AKangHealth’s longstanding contributions to the development of the new economy and new healthcare sector in Baiyun District, and expressed his expectation that an internet healthcare and big health industrial park centered on AKangHealth would be established in Baiyun District. This initiative aims to vigorously promote the development of the regional internet healthcare innovation industry, positioning the park as one of the representative forces driving digitalization in Baiyun District.

Mr. Xu Yuping, Chairman of the Board of Supervisors of China Medical Pharmaceutical Material Association

Mr. Xu Yuping, Chairman of the Supervisory Board of the China Medical Pharmaceutical Materials Association, stated that as a vice-chairman unit of the Association, AKangHealth has undertaken the development of branches such as the Primary Healthcare Branch and the Hospital-Adjacent Pharmacy Branch. The successful completion of its Series B financing signals AKangHealth’s enhanced capacity to drive the development of the pharmaceutical industry. Leveraging the broad platform of the China Medical Pharmaceutical Materials Association, stakeholders will jointly promote the construction of digital platforms for primary healthcare services and co-establish regional integrated health service platforms.

Mr. Chen Xilin, Vice President of AKangHealth Group / General Manager of Yunyao Technology

Mr. Chen Xilin, Vice President of AKangHealth Group and General Manager of Yunyao Technology, introduced the positioning, target demographics, and immense market potential of the Regional Medical and Health Platform. Leveraging AKangHealth’s five-year foundation in its “One Body, Five Dimensions” system technology platform, supply chain network, warehousing and logistics system, and grassroots medical infrastructure, the company employs a “Five-Power Empowerment” model—integrating technology, business model, operations, capital, and culture—to build a new localized health service industrial platform. This initiative aims to reshape regional commercial value and establish AKangHealth as a leader in high-quality local medical services. Looking ahead, the goal is to replicate the “AKang Model” across 100 cities, empower one million terminal points, and serve 900 million residents in county-level and grassroots areas, ensuring they enjoy superior medical services and experiences.

Xu Yuping, Chairman of the Board of Supervisors of the China Medical Pharmaceutical Material Association; Li Junguo, Executive Vice President of Sinopharm Information; Liao Guanghui, Director of the New Retail Research Institute under the Research Academy of the China Medical Pharmaceutical Material Association; Kong Xiaoxia, Executive President of Zhejiang Weikang Pharmaceutical Co., Ltd.; Ke Huasong, Executive Vice President of the Primary Healthcare Branch of the China Medical Pharmaceutical Material Association and President of the Primary Healthcare (Guangdong) Branch; Lin Zhihua, Secretary-General of the New Channel Branch of the China Medical Pharmaceutical Material Association; Deng Jinhua, Vice President of the China Medical Pharmaceutical Material Association and Chairman of Hunan Chuji Tang; Zhang Linghui, Secretary-General of the Pharmaceutical Commerce Branch of the China Medical Pharmaceutical Material Association; Xie Mingyan, President of the CIO Compliance Promotion Association; Wang Lijue, Chairman of AKangHealth Group

Jointly Launching the Strategic Release of the AKang Regional Healthcare and Big Health Platform. Embarking on a New Journey in Regional Big Health!

Mr. Sun Dongbo, Senior Partner at Zhongye Capital

Mr. Sun Dongbo, Senior Partner at Zhongye Capital, analyzed the broad prospects of regional healthcare and wellness from a business perspective, highlighting the reshaping of commercial value at the grassroots level and the elevation of commercial value dimensions, with a promising future for regional healthcare and wellness platforms.

Liu Meiling, General Manager of the Internet Healthcare Division at AKangHealth Group

Ms. Liu Meiling, General Manager of the Internet Healthcare Division of AKangHealth Group, introduced the construction plan for the AKang Internet Healthcare and Big Health Digital Park, which serves as the headquarters for the national regional healthcare platform. Leveraging national policy support for internet hospitals and driven by new medical models, the park has established a domestic “Internet Healthcare Entrepreneurship Community,” developed the “AKang Cloud Medicine” internet hospital medical consortium, and provided one-stop services for building self-operated internet hospitals. Currently, this project has partnered with more than 50 pharmaceutical manufacturers and medical institutions, assisting them in establishing their own internet hospitals, constructing regional medical consortia, closing the loop on out-of-hospital markets, and seizing the high ground in the prescription outflow market. The park has built a new commercial operation system, including a new retail B2C + O2O operational framework, TP (Tmall Partner) services for industrial e-commerce, incubation for the pharmaceutical live-streaming industry, development of influencer physicians, internet hospital operations, a national chronic disease customer service center, and a medical talent training center capable of training over 1,000 professionals. By integrating upstream resources and strengthening downstream capabilities, it forms a new business model that empowers regional healthcare and big health.

Bank-Enterprise Collaboration Empowers Primary Healthcare

At the conference, Xiao Zhihua, President of the Dongpu Sub-branch of Bank of China in Guangzhou, Zou Yang, President of Guangfa Bank's Liede Sub-branch in Guangzhou, Sze To Yin Ha, Deputy General Manager of HSBC Guangzhou BranchShi Yunhua, President of the Shatai Sub-branch of Bank of Communications in GuangzhouRepresentatives from seven banks and Wang Lijue, Chairman of AKangHealth Group, jointly launched a bank-enterprise partnership to empower grassroots healthcare through financial services. By leveraging the strength of banking institutions, this initiative aims to build a financial service system for grassroots healthcare and promote its development.

Xiao Zhihua, President of the Dongpu Sub-branch, Bank of China, Guangzhou

Xiao Zhihua, President of the Bank of China’s Guangzhou Dongpu Branch, delivered a speech in which he fully affirmed AKangHealth’s pivotal role in advancing primary healthcare, actively fulfilling the responsibilities of pharmaceutical professionals and assuming social responsibility. As one of the five core forces empowering regional medical and general health platforms, financial capital will, through this strategic partnership, join hands to embark on a new Long March for primary healthcare, thereby benefiting the broader grassroots population.

Park Unveiling

Chen Heng, Secretary of the Party Working Committee of Yongping Subdistrict, Baiyun District; Xu Yuping, Chairman of the Board of Supervisors of the China Medical Pharmaceutical Materials Association; Li Ning, Deputy Director of the Industry and Commerce, Science and Technology Bureau of Baiyun District; Zhu Dongxuan, Chairman of Xueshan Property Management Co., Ltd.; Wang Lijue, Chairman of AKangHealth Group; and Guo Jianbiao, Co-founder of AKangHealth Group and Chairman of Nuojian Pharmaceutical, jointly unveiled the plaque for the AKang Internet Medical Industrial Park. The AKang Internet Medical Industrial Park marks a significant strategic shift for AKang from “pharmaceuticals” to “medical care.” Over the next three years, the park aims to become a provincial-level key industrial hub for internet healthcare and big health, leveraging Guangzhou’s core advantages in medical resources within South China to build the largest internet medical innovation zone in southern China. This initiative will comprehensively drive the rapid development of the internet medical innovation industry in Baiyun District.

As a close partner of AKangHealth, Weikang Pharmaceutical was the first to enter the industrial park, establishing a new business model that empowers the “Little AKang” ecosystem through an integrated online-plus-offline and B2C-plus-O2O approach, with the goal of achieving annual revenues exceeding RMB 20 million per store. In the future, more cooperative enterprises and innovative industries will settle in the park for incubation and development.

Weikang Pharmacy Grand Opening

Xu Yuping, Supervisor of the China Medical Products Association; Kong Xiaoxia, Executive President of Zhejiang Weikang Pharmaceutical Co., Ltd.; Liao Guanghui, Director of the New Retail Institute under the Research Academy of the China Medical Products Association; Deng Jinhua, Vice President of the China Medical Products Association and Chairman of Hunan Chuji Tang; Ke Huasong, Executive Vice President of the Primary Healthcare Branch of the China Medical Products Association and President of the Primary Healthcare (Guangdong) Branch; and Wang Lijue, Chairman of AKangHealth Group, participated in the ribbon-cutting ceremony for the opening of Weikang Pharmacy.

Compassion and original aspiration are the underlying strengths of AKangHealth, while innovation and perseverance constitute its growth DNA. Remaining true to its founding mission, AKangHealth embarks on a new journey toward its dreams. Leveraging the momentum of capital investment, it is rapidly establishing a strategic presence in regional healthcare hubs. With a patient-centric approach and technology-driven innovation, AKangHealth fosters deep platform connectivity and effective resource integration. By creating a closed-loop service ecosystem encompassing “medical care + pharmaceuticals + diagnostics + insurance,” it empowers regional commerce, positioning itself as a vehicle for leading high-quality medical services and jointly building a comprehensive, one-stop grassroots service network for the general public.

Campus Group Photo

Five Years of Perseverance, Relentless Pursuit, and Striving. A New Journey, A New Beginning!

We remain true to our original aspiration, fostering shared growth and symbiosis. With a healer’s compassionate heart, we bring convenience to people and offer them hope.

Mr. Xie Yong, CEO of Guangdong Zhongke Kechuang Venture Capital Management Co., Ltd.

Mr. Tan Qingzhong, General Manager of Shenzhen Suizi Wealth Management Co., Ltd.

Mr. Xie Yong, CEO of Guangdong Zhongke Kechuang Venture Capital Management Co., Ltd., and Mr. Tan Qingzhong, General Manager of Shenzhen Suizi Finance Management Co., Ltd., as representatives of the investors in AKangHealth’s Series B financing, expressed their full affirmation of the future value of AKangHealth’s development. The decision to invest in AKangHealth was made after extensive project due diligence and evaluation. The ultimate investment decision was driven by the recognition that AKangHealth’s core medical value lies not merely in any single link, service, or product, but in its comprehensive healthcare ecosystem platform. By integrating primary healthcare services and connecting upstream and downstream partners, this platform embodies the future potential that positions AKangHealth as a billion-dollar unicorn.